Healthcare has rarely been short of investment opportunities, but deciding where to look has become more complicated. Drugmakers are preparing for major patent expirations, medical-device companies are benefiting from new technologies and product launches, and the rapid expansion of AI is beginning to change how parts of the industry approach drug development, diagnostics, and patient care.
At the same time, some of the biggest healthcare companies are being forced to prove that the billions...
